- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.21%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 11 June, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth Plan-Growth Option | 5.24% | 0.21% | 0.93% | -0.5% | 4.19% | 4.12% | 21.96% | 12.22% | 20.74% | 15.21% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 11.58% | 0.36% | 1.85% | 1.72% | 9.56% | 10.05% | 25% | 15.27% | 22.91% | 13.33% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -8.13% | -0.55% | -0.69% | -1.73% | -0.2% | -5.65% | 9.57% | 9.22% | 11.07% | 11.5% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -1.68% | -1.06% | -3.1% | -3.79% | 5.24% | -2.86% | 16.75% | 17.48% | 17.29% | 15.06% |
| SBI PSU Fund - REGULAR PLAN -Growth | 0.22% | -0.7% | -1.87% | -2.86% | -3.02% | 4.36% | 28.14% | 22.04% | 18.1% | 14.77% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -10.45% | -0.77% | -1% | -4.57% | -1.03% | -11.06% | 7.07% | 11.95% | 13.4% | 13.37% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -10.27% | 7.14% | 3.79% | 2.14% | 67.04% | 22.66% | -10% | 40.12% | 34.25% | -3.81% |
Discrete returns (monthly)
| Month | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.48% | -2.59% | 2.16% | 0.82% | -1.31% | -4.73% | 5.23% | -4.93% | 5.96% | 2.29% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 12.48% | 1.66% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.45% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.55% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 13.92% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 8.45% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.41% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 5.96% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.42% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.15% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 3.86% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.36% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.24% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 3.15% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.15% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.87% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.81% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.77% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.64% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.43% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.17% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.02% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 1.94% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.90% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.72% |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.67% |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 1.51% |
| Sanofi Consumer Healthcare India Limited | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.16% |
| Suraksha Diagnostic Limited | SURAKSHA (INE877V01027) | Healthcare Services | 1.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.11% |
| Sanofi India Limited | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.94% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.93% |
| Akums Drugs and Pharmaceuticals Limited | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.88% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.67% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.62% |
| Indoco Remedies Limited | INDOCO (INE873D01024) | Pharmaceuticals & Biotechnology | 0.38% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 0.14% |
Portfolio data is as on date 31 March, 2026
NAV history
Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 11 June, 2026 | 535.8811 | 0.21% |
| 10 June, 2026 | 534.7805 | -0.32% |
| 9 June, 2026 | 536.4763 | 0.56% |
| 8 June, 2026 | 533.4764 | -0.05% |
| 5 June, 2026 | 533.7434 | 0.53% |
| 4 June, 2026 | 530.9284 | 0.11% |
| 3 June, 2026 | 530.3524 | 0.35% |
| 2 June, 2026 | 528.5113 | -0.07% |
| 1 June, 2026 | 528.9056 | -0.81% |
| 29 May, 2026 | 533.2115 | -1.2% |
| 27 May, 2026 | 539.7005 | -0.04% |
| 26 May, 2026 | 539.9347 | -0.33% |
| 25 May, 2026 | 541.7249 | 0.15% |
| 22 May, 2026 | 540.9123 | -1.52% |
| 21 May, 2026 | 549.2545 | 0.41% |
| 20 May, 2026 | 546.9917 | -0.3% |
| 19 May, 2026 | 548.6390 | 0.42% |
| 18 May, 2026 | 546.3386 | 0.26% |
| 15 May, 2026 | 544.9359 | 0.42% |
| 14 May, 2026 | 542.6506 | 2.03% |
| 13 May, 2026 | 531.8502 | 0.22% |
| 12 May, 2026 | 530.6674 | -1.47% |
| 11 May, 2026 | 538.5577 | 0.13% |
| 8 May, 2026 | 537.8319 | 0.28% |
| 7 May, 2026 | 536.3381 | 0.37% |
| 6 May, 2026 | 534.3662 | 2.2% |
| 5 May, 2026 | 522.8536 | -0.13% |
| 4 May, 2026 | 523.5409 | 1.25% |
| 30 April, 2026 | 517.0628 | -0.06% |
| 29 April, 2026 | 517.3505 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 535.8811 as on 11 June, 2026.What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 5.24% as on 11 June, 2026.What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 4.12% as on 11 June, 2026.What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 21.96% as on 11 June, 2026.What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.22% as on 11 June, 2026.What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.22% as on 11 June, 2026.